Cargando…

Gastrointestinal symptoms in COVID-19

SARS-CoV-2 infection manifests mainly by involving the respiratory system. Due to the presence of abdominal symptoms, the digestive system is clearly involved in the expression, transmission, and possible pathogenesis of COVID-19. There are many theories regarding the development of abdominal sympto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Konrad, Kaniewska, Magdalena, Rosołowski, Mariusz, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050985/ https://www.ncbi.nlm.nih.gov/pubmed/37007763 http://dx.doi.org/10.5114/pg.2021.112683

Ejemplares similares

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?
por: Lewandowski, Konrad, et al.
Publicado: (2021)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Skin and gastrointestinal symptoms in COVID-19
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
por: Nazarewska, Anna, et al.
Publicado: (2023)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Reply to van Lingen et al. Comment on “Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112”
por: Szczubełek, Martyna, et al.
Publicado: (2022)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Diet as therapeutic intervention in Crohn’s disease
por: Więcek, Martyna, et al.
Publicado: (2022)

Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices – recommendations of the Working Group of the National Consultant for Gastroenterology
por: Rosołowski, Mariusz, et al.
Publicado: (2014)

Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients
por: Kadaj-Lipka, Roland, et al.
Publicado: (2020)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Approach to endoscopic procedures during COVID-19 pandemic – not as expected
por: Ratyński, Tomasz, et al.
Publicado: (2020)

The Impact of Cardiovascular Risk Factors on the Course of COVID-19
por: Wilk-Sledziewska, Katarzyna, et al.
Publicado: (2022)

Show Me What You Have Inside—The Complex Interplay between SIBO and Multiple Medical Conditions—A Systematic Review
por: Sroka, Natalia, et al.
Publicado: (2022)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Selected personality traits and emotional disorders of women diagnosed with gastrointestinal disease – a pilot study
por: Piotrowicz, Grażyna, et al.
Publicado: (2022)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Etiology, diagnosis and treatment of infectious esophagitis
por: Rosołowski, Mariusz, et al.
Publicado: (2013)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club
por: Kadaj-Lipka, Roland, et al.
Publicado: (2018)

Management of acute pancreatitis (AP) – Polish Pancreatic Club recommendations
por: Rosołowski, Mariusz, et al.
Publicado: (2016)

The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review
por: Rydzewska-Rosołowska, Alicja, et al.
Publicado: (2020)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Jaszczuk, Kamil, et al.
Publicado: (2020)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
por: Szydlarska, Dorota, et al.
Publicado: (2019)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2017)

Butyric acid – a well-known molecule revisited
por: Borycka-Kiciak, Katarzyna, et al.
Publicado: (2017)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Socio-demographic characteristics of patients with diagnosed functional dyspepsia
por: Piotrowicz, Grażyna, et al.
Publicado: (2013)

Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
por: Lipiński, Michał, et al.
Publicado: (2017)

Acute pancreatitis and the weekend effect: does weekend admission affect patient outcome?
por: Lipiński, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_357sq499leg9jq5cjjr8ebnsfv